ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HRMY Harmony Biosciences Holdings Inc

33.58
0.06 (0.18%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 303,207
Bid Price 32.01
Ask Price 34.81
News -
Day High 33.98

Low
18.6112

52 Week Range

High
39.265

Day Low 32.62
Company Name Stock Ticker Symbol Market Type
Harmony Biosciences Holdings Inc HRMY NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 0.18% 33.58 18:15:00
Open Price Low Price High Price Close Price Prev Close
33.52 32.62 33.98 33.58 33.52
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,947 303,207 $ 33.48 $ 10,152,407 - 18.6112 - 39.265
Last Trade Time Type Quantity Stock Price Currency
18:01:46 5 $ 31.74 USD

Harmony Biosciences Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.91B 56.77M - 582.02M 128.85M 2.27 14.79
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Harmony Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HRMY Message Board. Create One! See More Posts on HRMY Message Board See More Message Board Posts

Historical HRMY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.9534.4431.7633.09254,812-0.37-1.09%
1 Month33.8934.4429.3531.69422,601-0.31-0.91%
3 Months31.4735.39529.3532.08355,7752.116.70%
6 Months33.8035.39518.611228.24568,708-0.22-0.65%
1 Year34.0039.26518.611231.40632,686-0.42-1.24%
3 Years29.1662.08518.611238.83512,8654.4215.16%
5 Years36.5062.08518.611238.74455,823-2.92-8.00%

Harmony Biosciences Description

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Your Recent History

Delayed Upgrade Clock